Adell Harriman & Carpenter Inc. cut its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) by 15.8% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 3,123 shares of the exchange traded fund’s stock after selling 584 shares during the quarter. […]